New Zealand has an impressive heritage when it comes to healthtech innovation, and today healthtech firms rank among some of our most globally successful businesses.
The sector shows significant growth potential. In the 2020-21 financial year, healthtech firms generated an estimated $2.85 billion in revenue, demonstrating a seven-year compound annual growth rate of 13%.
While device makers currently lead the charge, other healthtech categories are showing promise. For example, digital health, as well as diagnostics and therapeutics (including pharmaceuticals), are expanding significantly.
And New Zealand’s ecosystem of more than 120 healthtech companies is providing a rich pipeline of early-stage innovation and investment opportunities.
Several other organisations offer other types of support, such as training, investment guidance and connections to researchers and other experts. Some useful sites to explore include: